This is an important point Ringostar.
The clinical trials are running to plan and IHL-42X could be the first drug for OSA in a $5 billion per year market. IHL has $40m in the bank and big Pharma has a tonne of cash on the sidelines to deploy.
If IHL was a private company we’d all be sleeping soundly because the company has never been in better shape and the upside looks enormous and very real.
Unless you understand how to approach a volatile market you’ll just end up making an emotional decision over price.
My thoughts are, don’t be a screen junky. If the investment proposition hasn’t changed (personally I think that’s the case, in fact the story keeps getting better) then sometimes it’s better to just turn your computer off.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-13862
-
-
- There are more pages in this discussion • 6,035 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online